ECP
LUXAU

Empyrean Capital Partners’s Lux Health Tech Acquisition Corp. Units LUXAU Stock Holding History

Empyrean Capital Partners’s Portfolio LUXAU Stock Details LUXAU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,391,469
Closed -$16M – 188
2020
Q4 		$16M Buy
+1,391,469
New +$14.9M 0.52% 57

Other funds holding LUXAU

DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Empyrean Capital Partners's LUXAU Position: Q1 2021 in Review

Empyrean Capital Partners sold out of Lux Health Tech Acquisition Corp. Units (LUXAU) in Q1 2021, closing a stake of 1,391,469 shares — an estimated $16M sold.

Empyrean Capital Partners first reported a position in LUXAU in Q4 2020 and held it in 1 quarter. The position peaked at $16M in Q4 2020. 24 funds tracked by Wall St. Rank hold LUXAU as of Q1 2021.

  • Empyrean Capital Partners reported no remaining Lux Health Tech Acquisition Corp. Units position as of Q1 2021 after selling out during the quarter.
  • Empyrean Capital Partners sold 1,391,469 Lux Health Tech Acquisition Corp. Units shares in Q1 2021, an estimated $16M.
  • Empyrean Capital Partners first reported a position in Lux Health Tech Acquisition Corp. Units in Q4 2020 and held it in 1 quarter.
  • Empyrean Capital Partners's Lux Health Tech Acquisition Corp. Units position peaked at $16M in Q4 2020.
  • 24 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Units as of Q1 2021.

Based on Empyrean Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.